NCT07896655
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Study First Submitted
Endpoints
Primary
Distribution of Modified Rankin Scale Scores at 90 Days
Timeframe: 90 (±7) days after randomization
Secondary (7)
mortality at 90 (±7) days
Independent ambulation
Functional independence
Excellent outcome
Quality of life score
Show 2 moreShow less
Cerebral infarction volume
Vascular Re-occlusion Rate
Arms and interventions
Hypothermia groupExperimental
Following successful reperfusion with endovascular treatment (EVT), participants in the hypothermia group will receive a selective intra-arterial infusion of 350 mL of 4°C normal saline at a fixed rate of 30 mL/min. No dose escalation will be performed.
Normothermia groupActive comparator
Receive a total of 350 ml of room temperature (22-25°C) saline infusion based on EVT treatment; the infusion rate is the same as that of the hypothermia group
Procedures: Mechanical thrombectomy
Drugs: Normothermic saline infusion, 4°C saline infusion
Sites
2 sites in 1 country